Member Info for onlyprofit

Drnash78: What is your target price in the short term? I mean in August

If you research shares in issue, you will find out that it is not possible. NCYT (70.6m) and GDR(543.14M) so not possible.

Haha I was missing this comment (US to wake up) 😂😂😂

Legalwolf: Yes the rise was due to the draft recommendation, however, at that time there were fewer shares in the market as compared to today's market where 3 times more shares are in the market. So not sure if the share price would react the same way as last time on 31st July and we would see a double-digit number after a long time. My average is low (4.61) and holds 1.3 million shares - My target is 15p but maybe I am asking too much. At 15p the market capitalization would be £75M which is achievable in short terms with two great products.

Sorry not a chance of 15-20p after the huge dilution in the last placing - maximum it can reach after NICE approval 8 to 10p I believe.

Roger: You may call it foolishness to invest all your money in one share. We will find out very soon - only three weeks to go.

bighammer: It is a big "IF" but it is a fact that when it becomes reality, we all will celebrate.

I have invested all my money in GDR. The best practice is to spread your investment to avoid disappointment(Do not put all your eggs in one basket). My average is 4.61 and holding 1.3 million shares. If GDR fails I will lose a substantial amount. Stroke test NICE approval is the key to GDR survival.

Very tight spread: 1.6851 to sell, 1.6975 to buy

Https://www.genedrive.com/assays/cyp2c19-documentation.php

Certificate of analysis (COA) published on #GDR website shows production of CYP2C19 tests went from 299 April to May, up to a whopping 7597 May to June based on the lot number tested. Is someone expecting huge demand?https://x.com/Patjroche/status/1807701673248530938

Worth reading the reply z1co got on advfn today.

The email says that NICE already know the outcome regarding the test

The delay is because NICE is working in partnership with colleagues at NHS England and NHS Improvement, to develop a resource to support the implementation which will publish alongside the final guidance.

They are also saying that " resolution has concluded "

Hmmm, another delay. The price would drop tomorrow :-(

Why is the share price so low?

Moving up? Where ? In your dream 😂

Https://x.com/genedriveplc/status/1799037446090547496

Open offer shares have been dispatched into my IG account 😊

3.9M buy or sell?????

As per RNS 30 May 24:

Second Admission occurring no later than 8.00 a.m. on 3 June 2024 (or such later time and/or date as may be agreed between the Company and Peel Hunt, being no later than 8.00 a.m. on 17 June 2024).

10 July announcement Stockpickfree

Well said bighammer!

Reposting my previous comment: I agree with the comment posted on the ADVFN board and my opinion is the same.

From ADVFN board:

"I disagree slightly 10p is only 50m. Mkt cap after the dilution that's not massive market cap to achieve if they can start achieving break even. I admit they are some easy from that yet but the losses aren't that high compared to many other pharma companies so there is potential for this to go there and higher. First stop on that road is NICE

Even small profit as they grow would see that achieved on a decent PE"